Nisa Investment Advisors
INZY

Nisa Investment Advisors’s Inozyme Pharma INZY Stock Holding History

Nisa Investment Advisors’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-919
Closed -$3.68K – 3036
2025
Q2 		$3.68K Buy
919
+564
+159% +$1.4K ﹤0.01% 2499
2025
Q1 		$323 Buy
+355
New +$492 ﹤0.01% 2864
2024
Q4 		– Sell
-179
Closed -$936 – 3025
2024
Q3 		$936 Buy
179
+164
+1,093% +$851 ﹤0.01% 2595
2024
Q2 		$67 Sell
15
-9
-38% -$44 ﹤0.01% 2892
2024
Q1 		$184 Buy
+24
New +$132 ﹤0.01% 2654
2022
Q3 		– Sell
-4,800
Closed -$23K – 2610
2022
Q2 		$23K Buy
+4,800
New +$20.9K ﹤0.01% 2013
2021
Q4 		– Sell
-200
Closed -$2 – 2281
2021
Q3 		$2 Hold
200
– – ﹤0.01% 2291
2021
Q2 		$3 Buy
+200
New +$3.48K ﹤0.01% 2294

Nisa Investment Advisors's INZY Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 919 shares — an estimated $3.68K sold.

Nisa Investment Advisors first reported a position in INZY in Q2 2021 and held it in 8 quarters. The position peaked at $23K in Q2 2022. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • Nisa Investment Advisors reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 919 Inozyme Pharma shares in Q3 2025, an estimated $3.68K.
  • Nisa Investment Advisors first reported a position in Inozyme Pharma in Q2 2021 and held it in 8 quarters.
  • Nisa Investment Advisors's Inozyme Pharma position peaked at $23K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.